NEW

FDA Updates Information on Respirator Decontamination Systems

The U.S. Food and Drug Administration (FDA) is reissuing the Emergency Use Authorizations for decontamination systems that are authorized to decontaminate compatible N95 respirators for use by healthcare personnel (HCP) to prevent exposure to pathogenic biological...

First Patient Treated in Clinical Trial of BCL System

CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, announced that the first patient has been treated in its U.S. pivotal trial of the Breast Cancer Locator (BCL) System at Massachusetts General Hospital.

Rush Oak Park Hospital Adopts Surgical Workflow Technology, ExplORer Surgical, Increasing Team Confidence and Reducing OR Challenges

ExplORer Surgical, the only comprehensive intraoperative case support and workflow platform, has reinvented the way surgical support teams prepare and complete effective surgeries with two-way video for case support and remote proctoring to create a digitized playbook.

AORN Releases 2021 Guidelines for Perioperative Practice

The Association of periOperative Registered Nurses (AORN) has published the 2021 Guidelines for Perioperative Practice with six revised guidelines.

Nasal Decolonization in Pre-Operative Protocols: An Antiseptic Alternative to Antibiotics

by Rosie D. Lyles, MD, MHA, MSc; Head of Clinical Affairs, Clorox Healthcare

The Burden of Surgical Site Infection

In today’s dynamic healthcare environment, preventing surgical site infections (SSIs) is one of the greatest challenges. SSIs continue to rank as one of the most common types of healthcare-associated infections1, and are associated with significant direct and indirect financial and emotional costs to healthcare facilities and to patients. The majority of SSIs are caused by Staphylococcus aureus (S. aureus),2 and patient colonization with S. aureus is a major risk factor for SSIs.2

Decolonization Strategies to Reduce SSIs

Patient decolonization prior to surgery may help to reduce the risk of SSIs.3,4 Preadmission bathing or showering with chlorhexidine gluconate (CHG) is most commonly used to cleanse the skin. For nasal decolonizataion, the antibiotic mupirocin (brand name Bactroban) applied by the patient to the anterior nares twice daily for the five consecutive days prior to surgery has typically been used. However, concerns that resistance to mupirocin and low compliance may lead to decolonization failure has prompted the search for non-antibiotic alternatives.

Povidone iodine can be an effective antiseptic alternative to mupirocin for nasal decolonization when used as part of preoperative bundle that includes CHG bathing. In patients undergoing orthopedic surgeries, povidone iodine is as effective as mupirocin for nasal decolonization,4 and a bundle including nasal decolonization with povidone iodine, CHG bathing and a CHG oral rinse resulted in lower rates of SSIs compared to patients not decolonized.3 Universal decolonization with CHG and povidone iodine has also been shown to be as clinically effective but more cost effective than screening and decolonization with CHG and mupirocin.5 Studies have also shown that bacteria do not develop resistance to povidone iodine.6

An Antiseptic Alternative

Clorox Healthcare™ Nasal Antiseptic Swabs are pre-saturated with a sterile povidone iodine gel and can be used for nasal decolonization. The swabs are applied by the healthcare provider one hour prior to surgery which can increase the likelihood of compliance. The gel reduces 99.4% of S. aureus at 1 hour and maintains persistence through 12 hours.7 In a safety and tolerance study, 96% of patients experienced no discomfort and were satisfied with the overall experience.8

An effective decolonization protocol that includes skin bathing and nasal decolonization has been demonstrated to be effective in reducing the risk of SSIs. Clorox Healthcare™ Nasal Antiseptic Swabs, are an antiseptic alternative for nasal decolonization that eliminates the risk and complexity of antibiotic usage.

For more information about nasal decolonization, visit www.CloroxHealthcare.com/NasalAntisepticSwabs

References

  1. Sievert DM et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14.
  2. Kalmeijer MD et al. Nasal carriage of Staphylococcus aureus: Is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol. 2000;21:319-323.
  3. Bode LG, Kluytmans JA,Wertheim HF, et al. Preventing surgicalsite infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362(1):9–17.
  4. Phillips M et al. Preventing surgical site infections: a randomized, open-label trial of nasal Mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol. 2014 Jul;35(7):826-32.
  5. Torres EG et al. Is Preoperative Nasal Povidone-Iodine as Efficient and Cost-Effective as Standard Methicillin-Resistant Staphylococcus aureus Screening Protocol in Total Joint Arthroplasty? J Arthroplasty. 2016 Jan;31(1):215-8.
  6. Lanker Klossner B et al. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine. Dermatology. 1997;195 Suppl 2:10-3.
  7. Clorox Study #9550-005 (in vitro)
  8. The Clorox Services Company Study Number: 2015-002/2015-003.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X